Donato Mannina

1.3k total citations
24 papers, 292 citations indexed

About

Donato Mannina is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Donato Mannina has authored 24 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 9 papers in Hematology. Recurrent topics in Donato Mannina's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Donato Mannina is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Donato Mannina collaborates with scholars based in Italy, United Kingdom and Brazil. Donato Mannina's co-authors include Caterina Stelitano, Francesco Merli, Stefano Luminari, Luigi Rigacci, Emanuele Zucca, Graziella Pinotti, Barbara Botto, Manuel Gotti, Maria Giuseppina Cabras and Livio Gargantini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Donato Mannina

23 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donato Mannina Italy	9	193	80	76	64	62	24	292
Annalisa Gabriele Italy	8	255 1.3×	112 1.4×	87 1.1×	37 0.6×	58 0.9×	12	315
Sara Steffanoni Italy	7	176 0.9×	72 0.9×	114 1.5×	24 0.4×	26 0.4×	26	265
Ingrid Vášová Czechia	7	192 1.0×	153 1.9×	78 1.0×	35 0.5×	35 0.6×	35	293
Jonas Karlén Sweden	8	244 1.3×	91 1.1×	102 1.3×	48 0.8×	88 1.4×	11	404
Edita Kabíčková Czechia	11	295 1.5×	179 2.2×	150 2.0×	61 1.0×	61 1.0×	41	460
Lenka Šmardová Czechia	9	256 1.3×	220 2.8×	125 1.6×	24 0.4×	108 1.7×	28	407
Secundino Ferrer Spain	7	228 1.2×	57 0.7×	125 1.6×	24 0.4×	78 1.3×	19	344
Mattia Congia Italy	9	70 0.4×	24 0.3×	34 0.4×	42 0.7×	47 0.8×	27	327
Emanuela Merla Italy	11	297 1.5×	143 1.8×	83 1.1×	15 0.2×	44 0.7×	17	390
R. Quek Singapore	4	191 1.0×	65 0.8×	125 1.6×	59 0.9×	65 1.0×	20	254

Countries citing papers authored by Donato Mannina

Since Specialization

Citations

This map shows the geographic impact of Donato Mannina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donato Mannina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donato Mannina more than expected).

Fields of papers citing papers by Donato Mannina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donato Mannina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donato Mannina. The network helps show where Donato Mannina may publish in the future.

Co-authorship network of co-authors of Donato Mannina

This figure shows the co-authorship network connecting the top 25 collaborators of Donato Mannina. A scholar is included among the top collaborators of Donato Mannina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donato Mannina. Donato Mannina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campo, C, et al.. (2025). Bispecific Antibodies and Antibody–Drug Conjugates in Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma, Focusing on Diffuse Large B-Cell Lymphoma. Cancers. 17(15). 2479–2479.

Cancemi, Gabriella, et al.. (2025). Single-Agent and Associated Therapies with Monoclonal Antibodies: What About Follicular Lymphoma?. Cancers. 17(10). 1602–1602. 2 indexed citations

Vetro, Calogero, Donato Mannina, Maria Enza Mitra, et al.. (2022). Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes. Journal of Clinical Medicine. 11(6). 1665–1665. 2 indexed citations

Markovic, Uroš, Alessandra Romano, Vittorio Del Fabro, et al.. (2021). Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey. Frontiers in Oncology. 11. 624405–624405. 7 indexed citations

Raso, Simona, Mariasanta Napolitano, Giulia Arrigo, et al.. (2021). Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis. Annals of Hematology. 100(3). 653–659. 3 indexed citations

Boccadoro, Mario, Patrizia Berto, Sara Bringhen, et al.. (2021). Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus. SHILAP Revista de lepidopterología. 8. 80–86. 1 indexed citations

Genuardi, Elisa, Marco Beccuti, Donato Mannina, et al.. (2021). Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial. British Journal of Haematology. 194(2). 378–381. 4 indexed citations

Tucci, Alessandra, Gerardo Musuraca, Federica Cavallo, et al.. (2021). A Simplified Geriatric Assessment (sGA) Can Identify Older Patients with Relapse/Refractory (R/R) Aggressive Lymphoma Suitable for Autologous Stem Cell Transplantation (ASCT): Final Results of Recanz Multicentre Prospective Phase 2 Study By the Fondazione Italiana Linfomi (FIL). Blood. 138(Supplement 1). 2496–2496. 2 indexed citations

Ferreri, Andrés J.M., Marianna Sassone, Elisabetta Miserocchi, et al.. (2020). Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum. Blood Advances. 4(6). 1013–1019. 9 indexed citations

10.

Martino, Massimo, Mercedes Gori, Giovanni Tripepi, et al.. (2019). A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant. Annals of Hematology. 99(2). 331–341. 4 indexed citations

11.

Pennisi, Maria Stella, Stefania Stella, Silvia Rita Vitale, et al.. (2019). BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors. Frontiers in Oncology. 9. 764–764. 12 indexed citations

12.

Zallio, Francesco, Stefania Tamiazzo, Chiara Monagheddu, et al.. (2016). Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL). British Journal of Haematology. 172(6). 879–888. 19 indexed citations

13.

Napolitano, Mariasanta, Alessandra Malato, Giorgia Saccullo, et al.. (2015). Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study. Leukemia & lymphoma. 57(1). 116–119. 17 indexed citations

14.

Ceriani, Luca, Maurizio Martelli, Pier Luigi Zinzani, et al.. (2015). Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma. Blood. 126(8). 950–956. 134 indexed citations

15.

Napolitano, Mariasanta, Giorgia Saccullo, Alessandra Malato, et al.. (2014). Management of Venous Thromboembolism (VTE) in Patients with Acute Leukemia: Results from a Multicenter Study. Blood. 124(21). 3688–3688. 1 indexed citations

16.

Ferrario, Andrea, Alessandro Pulsoni, Giuseppe Rossi, et al.. (2011). Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B‐cell nonfollicular lymphomas. Cancer. 118(16). 3954–3961. 18 indexed citations

17.

Renzo, Nicola Di, Antonella Montanini, Donato Mannina, et al.. (2010). Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL). Supportive Care in Cancer. 19(10). 1505–1510. 20 indexed citations

18.

Ferrario, Andrea, Francesco Merli, Stefano Luminari, et al.. (2010). Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trialof the Gruppo Italiano per lo Studio dei Linfomi (GISL). Annals of Hematology. 90(3). 323–330. 9 indexed citations

19.

Mannina, Donato, Stefano Luminari, Alessandra Dondi, et al.. (2009). Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi. Leukemia & lymphoma. 51(3). 422–429. 2 indexed citations

20.

Brugiatelli, Maura, et al.. (2007). B-cell chronic lymphocytic leukemia: clinical impact of biological prognostic factors and updated treatment strategies.. PubMed. 129 Suppl 3. 26–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact